Nefise Nazlı Yenigül
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nefise Nazlı Yenigül has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Burcu Dincgez
University of Health Sciences, Turkey
7 shared publications - Emre Başer
Yozgat Bozok University Faculty of Medicine, Department of Obstetrics and Gynecology, Yozgat, Turkey
6 shared publications - Oya Aldemir
UNIVERSITY OF HEALTH SCIENCES, ANKARA ETLİK ZÜBEYDE HANIM HEALTH RESEARCH CENTER FOR GYNECOLOGICAL DISEASES
6 shared publications - Berna Dilbaz
Department of Obstetrics and Gynecology, University of Health Sciences School of Medicine Ankara Etlik City Hospital
5 shared publications - Elif Yüce Bilgin
Department of Obstetrics and Gynecology Basaksehir Cam Ve Sakura City Hospital Istanbul Turkey
5 shared publications - Runa Özelçi
Department of Gynecology and Obstetrics, University of Health Sciences, Etlik Zübeyde Hanım Women’s Health Training and Research Hospital, Ankara 06620, Turkey
5 shared publications
Latest Publications
- 15 June 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (6) , e70372
Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomized, Double‐Blind, Placebo‐Controlled Trial
Objective: Postpartum hemorrhage (PPH) remains a major cause of maternal morbidity despite standard active management of the third stage of labor. Evidence regarding the prophylactic use of tranexamic acid (TA) after vaginal delivery, particularly according to PPH risk stratification, is limited. This study aimed to evaluate the efficacy of prophylactic intravenous tranexamic acid administered after vaginal delivery in reducing postpartum blood loss. The primary outcome was measured blood loss during the third and fourth stages of labor. Secondary outcomes included the incidence of uterine atony, need for blood transfusion, requirement for additional uterotonics, and treatment‐related adverse effects, assessed separately in low‐ and high‐risk PPH groups. Materials and Methods: This double‐blind, prospective, randomized controlled trial included 480 singleton pregnant women aged 18–45 years who delivered at ≥ 34 weeks of gestation. Participants were first stratified according to postpartum hemorrhage (PPH) risk as low‐risk ( n = 240) or high‐risk ( n = 240). Within each risk group, women were randomly assigned in a 1:1 ratio to receive either intravenous tranexamic acid (1 g) or placebo after vaginal delivery (120 participants per treatment arm in each risk group). Results: In low‐risk patients, both the collected blood volume and estimated blood loss were significantly lower in the tranexamic acid (TA) group compared with placebo. In high‐risk patients, TA administration was associated with significantly reduced collected blood volume and estimated blood loss, as well as a lower incidence of uterine atony. In addition, the need for blood transfusion and additional uterotonic use was lower in patients receiving TA, particularly in the high‐risk group. No clinically significant differences were observed in laboratory safety parameters, including D‐dimer levels. Conclusion: Prophylactic tranexamic acid administration after vaginal delivery significantly reduced postpartum blood loss compared with placebo. While TA was effective in reducing blood loss in both low‐ and high‐risk patients, a significant reduction in uterine atony was observed only in the high‐risk group. No major adverse effects related to TA were identified, suggesting that TA was well tolerated in the study population. Major maternal morbidity outcomes were not assessed in this study.
- 15 June 2026
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 52 (6) , e70372
Efficacy of Prophylactic Tranexamic Acid Use After Vaginal Delivery According to Postpartum Hemorrhage Risk: Randomized, Double‐Blind, Placebo‐Controlled Trial
Objective: Postpartum hemorrhage (PPH) remains a major cause of maternal morbidity despite standard active management of the third stage of labor. Evidence regarding the prophylactic use of tranexamic acid (TA) after vaginal delivery, particularly according to PPH risk stratification, is limited. This study aimed to evaluate the efficacy of prophylactic intravenous tranexamic acid administered after vaginal delivery in reducing postpartum blood loss. The primary outcome was measured blood loss during the third and fourth stages of labor. Secondary outcomes included the incidence of uterine atony, need for blood transfusion, requirement for additional uterotonics, and treatment‐related adverse effects, assessed separately in low‐ and high‐risk PPH groups. Materials and Methods: This double‐blind, prospective, randomized controlled trial included 480 singleton pregnant women aged 18–45 years who delivered at ≥ 34 weeks of gestation. Participants were first stratified according to postpartum hemorrhage (PPH) risk as low‐risk ( n = 240) or high‐risk ( n = 240). Within each risk group, women were randomly assigned in a 1:1 ratio to receive either intravenous tranexamic acid (1 g) or placebo after vaginal delivery (120 participants per treatment arm in each risk group). Results: In low‐risk patients, both the collected blood volume and estimated blood loss were significantly lower in the tranexamic acid (TA) group compared with placebo. In high‐risk patients, TA administration was associated with significantly reduced collected blood volume and estimated blood loss, as well as a lower incidence of uterine atony. In addition, the need for blood transfusion and additional uterotonic use was lower in patients receiving TA, particularly in the high‐risk group. No clinically significant differences were observed in laboratory safety parameters, including D‐dimer levels. Conclusion: Prophylactic tranexamic acid administration after vaginal delivery significantly reduced postpartum blood loss compared with placebo. While TA was effective in reducing blood loss in both low‐ and high‐risk patients, a significant reduction in uterine atony was observed only in the high‐risk group. No major adverse effects related to TA were identified, suggesting that TA was well tolerated in the study population. Major maternal morbidity outcomes were not assessed in this study.
- 13 March 2026
- Published by Elsevier in F&S Science
- Vol. 7 (4) , 339-345
Effects of letrozole alone or combined with a gonadotropin-releasing hormone agonist on inflammation, folliculogenesis, and estrogen levels in a rat model of peritoneal endometriosis
- 13 March 2026
- Published by Elsevier in F&S Science
- Vol. 7 (4) , 339-345
Effects of letrozole alone or combined with a gonadotropin-releasing hormone agonist on inflammation, folliculogenesis, and estrogen levels in a rat model of peritoneal endometriosis
- 3 February 2026
- Published by Georg Thieme Verlag KG in Zeitschrift für Geburtshilfe und Neonatologie
- Vol. 230 (03) , 201-208
A New Second-Trimester Scoring System To Predict Preterm Birth
To create a new scoring system for predicting preterm birth by incorporating second-trimester sonographic measurements, including cervical length, uterocervical angle, and lower uterine segment myometrial thickness, along with cervical dilation. This prospective study included 252 pregnant women who were admitted to a university-affiliated research hospital between 16 and 24 gestational weeks. Participants were followed and categorized into two groups: preterm birth group (n=40) and term birth group (n=212). Cervical length, uterocervical angle, and myometrial thickness were measured and the predictive role of these parameters for preterm birth was evaluated. A new scoring system was developed based on the identified cut-off values. A cervical length≤36.3 mm predicted preterm birth with 85% sensitivity and 73.1% specificity (p102.1 degrees predicted it with 92.5% sensitivity and 54.3% specificity (p<0.001, AUC=0.767). Additionally, a myometrial thickness≤5.7 mm predicted preterm birth with 90% sensitivity and 37.4% specificity (p=0.002, AUC=0.634). A new scoring system score≥2 predicted preterm birth with 75% sensitivity and 89.6% specificity (p<0.001, AUC=0.871). In the validation group, a total score≥2 predicted preterm birth with 70.6% sensitivity and 90.4% specificity (p<0.001, AUC=0.826). This scoring system, incorporating cervical length, uterocervical angle, myometrial thickness, and cervical dilatation, offers a potential alternative to digital cervical examination, a subjective method for predicting preterm birth.
- 3 February 2026
- Published by Georg Thieme Verlag KG in Zeitschrift für Geburtshilfe und Neonatologie
- Vol. 230 (03) , 201-208
A New Second-Trimester Scoring System To Predict Preterm Birth
To create a new scoring system for predicting preterm birth by incorporating second-trimester sonographic measurements, including cervical length, uterocervical angle, and lower uterine segment myometrial thickness, along with cervical dilation. This prospective study included 252 pregnant women who were admitted to a university-affiliated research hospital between 16 and 24 gestational weeks. Participants were followed and categorized into two groups: preterm birth group (n=40) and term birth group (n=212). Cervical length, uterocervical angle, and myometrial thickness were measured and the predictive role of these parameters for preterm birth was evaluated. A new scoring system was developed based on the identified cut-off values. A cervical length≤36.3 mm predicted preterm birth with 85% sensitivity and 73.1% specificity (p102.1 degrees predicted it with 92.5% sensitivity and 54.3% specificity (p<0.001, AUC=0.767). Additionally, a myometrial thickness≤5.7 mm predicted preterm birth with 90% sensitivity and 37.4% specificity (p=0.002, AUC=0.634). A new scoring system score≥2 predicted preterm birth with 75% sensitivity and 89.6% specificity (p<0.001, AUC=0.871). In the validation group, a total score≥2 predicted preterm birth with 70.6% sensitivity and 90.4% specificity (p<0.001, AUC=0.826). This scoring system, incorporating cervical length, uterocervical angle, myometrial thickness, and cervical dilatation, offers a potential alternative to digital cervical examination, a subjective method for predicting preterm birth.
- 1 January 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (05) , 378-383
The predictive role of amniotic fluid and serum tenascin X foradverse perinatal outcomes
- 1 January 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 16 (05) , 378-383
The predictive role of amniotic fluid and serum tenascin X foradverse perinatal outcomes
- 8 December 2025
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 64 (4) , 665-673
Risk factors and outcomes of conversion to laparotomy of total laparoscopic hysterectomy: A single center experience
Aim: This study aimed to analyze the risk factors and outcomes associated with conversion of total laparoscopic hysterectomy (TLH) to laparotomy in patients undergoing surgery for benign gynecologic conditions. Materials and Methods: A retrospective analysis was conducted of 160 women aged 35 to 70 years who underwent TLH or a procedure that started laparoscopically but required conversion to laparotomy between May 2016 and August 2021. Patients with suspected malignancy, previous oncologic procedures or incomplete data were excluded. Data collected included demographics, surgical indications, surgeon experience, intraoperative complications, and outcomes such as hospitalization, blood transfusion requirements, and intensive care unit (ICU) admission. Statistical analyses were performed to identify significant risk factors for conversion. Results: Of the 160 patients, 81 (50.6%) completed surgery laparoscopically, while 79 (49.4%) required conversion to laparotomy. The main reasons for conversion were adhesions (41.8%) and a large uterus (27.8%). Conversion cases had significantly longer hospital stays (p = 0.012), a higher rate of blood transfusion (p = 0.006) and a higher need for ICU admission (p = 0.011). Surgeon experience was not a statistically significant factor for conversion rates (p = 0.198), although experienced surgeons encountered more cases with the large uterus. Conclusion: Conversion from TLH to laparotomy is associated with increased morbidity, including longer hospital stays and higher transfusion rates. Adhesions and large uterine size were identified as major risk factors. Preoperative assessment and careful planning may reduce the need for conversion and improve patient outcomes.
- 8 December 2025
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 64 (4) , 665-673
Risk factors and outcomes of conversion to laparotomy of total laparoscopic hysterectomy: A single center experience
Aim: This study aimed to analyze the risk factors and outcomes associated with conversion of total laparoscopic hysterectomy (TLH) to laparotomy in patients undergoing surgery for benign gynecologic conditions. Materials and Methods: A retrospective analysis was conducted of 160 women aged 35 to 70 years who underwent TLH or a procedure that started laparoscopically but required conversion to laparotomy between May 2016 and August 2021. Patients with suspected malignancy, previous oncologic procedures or incomplete data were excluded. Data collected included demographics, surgical indications, surgeon experience, intraoperative complications, and outcomes such as hospitalization, blood transfusion requirements, and intensive care unit (ICU) admission. Statistical analyses were performed to identify significant risk factors for conversion. Results: Of the 160 patients, 81 (50.6%) completed surgery laparoscopically, while 79 (49.4%) required conversion to laparotomy. The main reasons for conversion were adhesions (41.8%) and a large uterus (27.8%). Conversion cases had significantly longer hospital stays (p = 0.012), a higher rate of blood transfusion (p = 0.006) and a higher need for ICU admission (p = 0.011). Surgeon experience was not a statistically significant factor for conversion rates (p = 0.198), although experienced surgeons encountered more cases with the large uterus. Conclusion: Conversion from TLH to laparotomy is associated with increased morbidity, including longer hospital stays and higher transfusion rates. Adhesions and large uterine size were identified as major risk factors. Preoperative assessment and careful planning may reduce the need for conversion and improve patient outcomes.
- 25 July 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 54 (1) , 5-11
The Predictive Role of Cervical Volume, Cervical Length, and Uterocervical Angle for Preterm Birth
Objectives: Predictive tests for preterm birth are considered extremely important considering the associated morbidities. Here, we aimed to assess the predictive role of cervical volume for preterm birth and compare this role with uterocervical angle and cervical length. Additionally, we aimed to evaluate the success of combinations of cervical volume, uterocervical angle, and cervical length in predicting preterm birth. Methods: A total of 485 pregnant women between 16 and 24th gestational weeks of gestation were included in this prospective observational study. Then, the patients were grouped as preterm and term births. The clinical characteristics, obstetric outcomes, and sonographic findings including uterocervical angle, cervical length, and cervical volume were compared between groups. The predictive roles of sonographic findings for preterm birth were analyzed by receiver operating characteristic curve and regression analysis. Result: Cervical length ≤ 35.7 mm predicted preterm birth with 81.16% sensitivity and 79.81% specificity ( p < 0.001, AUC = 0.843) while uterocervical angle > 94.9° predicted it with 98.55% sensitivity and 54.57% specificity ( p < 0.001, AUC = 0.751). Cervical volume ≤ 30.4 mm 3 predicted preterm birth with 86.96% sensitivity and 77.4% specificity ( p < 0.001, AUC = 0.886). No significant difference was found between cervical length and cervical volume, both of which are superior to uterocervical angle in predicting preterm birth. The combination of cervical length, uterocervical angle, and cervical volume increases the risk of preterm birth by approximately 153 times. Conclusion: Cervical volume could be considered a new predictor for preterm birth. Moreover, its use with cervical length and uterocervical angle may bring us closer to a more successful prediction of preterm birth.
- 25 July 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 54 (1) , 5-11
The Predictive Role of Cervical Volume, Cervical Length, and Uterocervical Angle for Preterm Birth
Objectives: Predictive tests for preterm birth are considered extremely important considering the associated morbidities. Here, we aimed to assess the predictive role of cervical volume for preterm birth and compare this role with uterocervical angle and cervical length. Additionally, we aimed to evaluate the success of combinations of cervical volume, uterocervical angle, and cervical length in predicting preterm birth. Methods: A total of 485 pregnant women between 16 and 24th gestational weeks of gestation were included in this prospective observational study. Then, the patients were grouped as preterm and term births. The clinical characteristics, obstetric outcomes, and sonographic findings including uterocervical angle, cervical length, and cervical volume were compared between groups. The predictive roles of sonographic findings for preterm birth were analyzed by receiver operating characteristic curve and regression analysis. Result: Cervical length ≤ 35.7 mm predicted preterm birth with 81.16% sensitivity and 79.81% specificity ( p < 0.001, AUC = 0.843) while uterocervical angle > 94.9° predicted it with 98.55% sensitivity and 54.57% specificity ( p < 0.001, AUC = 0.751). Cervical volume ≤ 30.4 mm 3 predicted preterm birth with 86.96% sensitivity and 77.4% specificity ( p < 0.001, AUC = 0.886). No significant difference was found between cervical length and cervical volume, both of which are superior to uterocervical angle in predicting preterm birth. The combination of cervical length, uterocervical angle, and cervical volume increases the risk of preterm birth by approximately 153 times. Conclusion: Cervical volume could be considered a new predictor for preterm birth. Moreover, its use with cervical length and uterocervical angle may bring us closer to a more successful prediction of preterm birth.
- 10 January 2025
- Published by Academician Publishing
- p. 1-4
Fetal Kalp Hızı Monitorizasyon Tarihçe
- 8 November 2024
- Published by Taylor & Francis in Biomarkers
- Vol. 29 (8) , 518-527
The role of pentraxin 3 and cathepsin B levels in pregnancies complicated by preeclampsia
The objective of this study was to compare the levels of cathepsin B and pentraxin 3 in maternal serum of pregnant women with preeclampsia in the second trimester, to ascertain the impact of these levels on maternal and fetal outcomes, and to present a comprehensive analysis of the combined effects of cathepsin B and pentraxin 3 levels. This prospective case-control study was conducted at Bursa Yuksek Ihtisas Training and Research Hospital between 1 January 2022 and 31 December 2022. The study included 78 pregnant women diagnosed with preeclampsia and 78 healthy pregnant women in the second trimester, between the ages of 18 and 45. Once a diagnosis of preeclampsia was established, maternal serum samples were obtained from the pregnant women prior to the initiation of any therapeutic intervention. Once all samples had been collected, the values for cathepsin B and pentraxin 3 were determined using the ELISA method. The results demonstrated a statistically significant elevation in the levels of pentraxin 3 (p = 0.008) and cathepsin B (p = 0.005) in pregnancies affected by preeclampsia when compared to those deemed healthy. Moreover, pentraxin-3 (p = 0.007) and cathepsin B (p = 0.002) were found to be significantly elevated in severe preeclampsia compared to mild preeclampsia. A comparison of the groups with and without HELLP syndrome revealed no statistically significant difference between the two groups. The ROC analysis revealed that the Cathepsin B 7.04 cut-off value was statistically significantly associated with the prediction of preeclampsia in all cases, with a sensitivity of 78.2% and a specificity of 47.4% (p = 0.005, AUC = 0.631). The levels of CB and PTX3 may be employed as biomarkers to facilitate the early diagnosis of PE during the second trimester. Furthermore, these biomarkers may prove to be promising for the prediction of PE severity.
- 8 November 2024
- Published by Taylor & Francis in Biomarkers
- Vol. 29 (8) , 518-527
The role of pentraxin 3 and cathepsin B levels in pregnancies complicated by preeclampsia
The objective of this study was to compare the levels of cathepsin B and pentraxin 3 in maternal serum of pregnant women with preeclampsia in the second trimester, to ascertain the impact of these levels on maternal and fetal outcomes, and to present a comprehensive analysis of the combined effects of cathepsin B and pentraxin 3 levels. This prospective case-control study was conducted at Bursa Yuksek Ihtisas Training and Research Hospital between 1 January 2022 and 31 December 2022. The study included 78 pregnant women diagnosed with preeclampsia and 78 healthy pregnant women in the second trimester, between the ages of 18 and 45. Once a diagnosis of preeclampsia was established, maternal serum samples were obtained from the pregnant women prior to the initiation of any therapeutic intervention. Once all samples had been collected, the values for cathepsin B and pentraxin 3 were determined using the ELISA method. The results demonstrated a statistically significant elevation in the levels of pentraxin 3 (p = 0.008) and cathepsin B (p = 0.005) in pregnancies affected by preeclampsia when compared to those deemed healthy. Moreover, pentraxin-3 (p = 0.007) and cathepsin B (p = 0.002) were found to be significantly elevated in severe preeclampsia compared to mild preeclampsia. A comparison of the groups with and without HELLP syndrome revealed no statistically significant difference between the two groups. The ROC analysis revealed that the Cathepsin B 7.04 cut-off value was statistically significantly associated with the prediction of preeclampsia in all cases, with a sensitivity of 78.2% and a specificity of 47.4% (p = 0.005, AUC = 0.631). The levels of CB and PTX3 may be employed as biomarkers to facilitate the early diagnosis of PE during the second trimester. Furthermore, these biomarkers may prove to be promising for the prediction of PE severity.
- Open Access
- 25 April 2024
- Published by Academician Publishing
Güncel Kadın Hastalıkları ve Doğum Çalışmaları
Otoi̇mmun Hastalıklar Ektopi̇k Gebeli̇k Geli̇şi̇mi̇ İçi̇n Bi̇r Ri̇sk Faktör Selçuk KAPLAN Adolesanlarda Endometri̇ozi̇s Hastalığının Yönetim Ayşe Rabia ŞENKAYA Ovaryen PRP Uygulamasının IVF/ICSI Sonuçlar Üzeri̇ne Etki̇si Nefise Nazlı YENİGÜL Tekrarlayan İmplantasyon Başarısızlığında Endometri̇al Hasarlamanın Rolü Rulin DENİZ IVF Tedavi̇leri̇nde Lüteal Faz Desteği Veysel TOPRAK Özcan BUDAK Aşırı Akti̇f Mesane Sendromuna Genel Bakış ve Hastaya Özel Tedavi̇de Yeni̇ Yaklaşım İsmail ALAY Ecem EREN Radyofrekans ile Labi̇oplasti Eser AĞAR Sık Görülen Vaji̇nal Enfeksi̇yonlar ile Yüksek Ri̇skli̇ Human Papi̇lloma Vi̇rus Varlığı Arasındaki̇ İlişkisi Selçuk KAPLAN Embri̇yo Seçi̇m Kri̇terleri Deniz KULAKSIZ
- 25 April 2024
- Published by Academician Publishing
Open AccessGüncel Kadın Hastalıkları ve Doğum Çalışmaları
Otoi̇mmun Hastalıklar Ektopi̇k Gebeli̇k Geli̇şi̇mi̇ İçi̇n Bi̇r Ri̇sk Faktör Selçuk KAPLAN Adolesanlarda Endometri̇ozi̇s Hastalığının Yönetim Ayşe Rabia ŞENKAYA Ovaryen PRP Uygulamasının IVF/ICSI Sonuçlar Üzeri̇ne Etki̇si Nefise Nazlı YENİGÜL Tekrarlayan İmplantasyon Başarısızlığında Endometri̇al Hasarlamanın Rolü Rulin DENİZ IVF Tedavi̇leri̇nde Lüteal Faz Desteği Veysel TOPRAK Özcan BUDAK Aşırı Akti̇f Mesane Sendromuna Genel Bakış ve Hastaya Özel Tedavi̇de Yeni̇ Yaklaşım İsmail ALAY Ecem EREN Radyofrekans ile Labi̇oplasti Eser AĞAR Sık Görülen Vaji̇nal Enfeksi̇yonlar ile Yüksek Ri̇skli̇ Human Papi̇lloma Vi̇rus Varlığı Arasındaki̇ İlişkisi Selçuk KAPLAN Embri̇yo Seçi̇m Kri̇terleri Deniz KULAKSIZ
- 18 March 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 44 (7) , 1029-1034
Does Bisphenol-A play a role in the development of neural tube defects?
Objective In this study, we aimed to evaluate BPA levels in the maternal serum and amniotic fluid of patients diagnosed with NTD. In addition, we wanted to investigate the relationship between neurodevelopmental defects, such as neural tube defects (NTD), and BPA levels. Study design This prospective observational study was carried out at Bursa Yüksek İhtisas Training and Research Hospital between April 15, 2021, and April 15, 2022. The study consisted of 92 patients between the ages of 18–45 who had an amniocentesis at 15–22 weeks of gestation. The patients were divided into two groups according to the indications of amniocentesis. Group 1 contained the patients with abnormal maternal serum screening results or cell-free DNA results and abnormal ultrasonography findings (45 patients). Group 2 contained the patients with a pre-diagnosis of NTD (47 patients). The first 5 cc fluids and maternal serum samples taken during the amniocentesis procedure of all patients were delivered to the biochemistry laboratory. The BPA values between groups were compared. Results A statistically significant difference was found between the two groups in terms of amniotic fluid BPA levels (36.66 (19.00:82.00) and 39.62 (19.02–73.87)) and maternal blood BPA levels (22.26 (12.60–228) and 47.81 (12.89–228.39)). In cases with NTD, amniotic fluid BPA levels and maternal blood BPA levels were significantly higher than the control group. When AUC values were compared, the AFP numerical value was higher than the amniotic fluid and maternal blood BPA levels. Conclusion Plastic, which is indispensable for modern life, may negatively affect fetal development in intrauterine life. The data in this study says that high maternal blood BPA may be associated with NTD.
- 18 March 2024
- Published by Springer Nature in Journal of Perinatology
- Vol. 44 (7) , 1029-1034
Does Bisphenol-A play a role in the development of neural tube defects?
Objective In this study, we aimed to evaluate BPA levels in the maternal serum and amniotic fluid of patients diagnosed with NTD. In addition, we wanted to investigate the relationship between neurodevelopmental defects, such as neural tube defects (NTD), and BPA levels. Study design This prospective observational study was carried out at Bursa Yüksek İhtisas Training and Research Hospital between April 15, 2021, and April 15, 2022. The study consisted of 92 patients between the ages of 18–45 who had an amniocentesis at 15–22 weeks of gestation. The patients were divided into two groups according to the indications of amniocentesis. Group 1 contained the patients with abnormal maternal serum screening results or cell-free DNA results and abnormal ultrasonography findings (45 patients). Group 2 contained the patients with a pre-diagnosis of NTD (47 patients). The first 5 cc fluids and maternal serum samples taken during the amniocentesis procedure of all patients were delivered to the biochemistry laboratory. The BPA values between groups were compared. Results A statistically significant difference was found between the two groups in terms of amniotic fluid BPA levels (36.66 (19.00:82.00) and 39.62 (19.02–73.87)) and maternal blood BPA levels (22.26 (12.60–228) and 47.81 (12.89–228.39)). In cases with NTD, amniotic fluid BPA levels and maternal blood BPA levels were significantly higher than the control group. When AUC values were compared, the AFP numerical value was higher than the amniotic fluid and maternal blood BPA levels. Conclusion Plastic, which is indispensable for modern life, may negatively affect fetal development in intrauterine life. The data in this study says that high maternal blood BPA may be associated with NTD.